vs
PG&E Corporation（PCG）与Stryker Corporation（SYK）财务数据对比。点击上方公司名可切换其他公司
Stryker Corporation的季度营收约是PG&E Corporation的1.0倍（$7.2B vs $6.9B），PG&E Corporation净利率更高（12.9% vs 11.8%，领先1.0%），PG&E Corporation同比增速更快（15.0% vs 11.4%），过去两年Stryker Corporation的营收复合增速更高（16.9% vs 7.2%）
PG&E Corporation是美国由投资者持有运营的公用事业企业，总部坐落于加利福尼亚州奥克兰市凯撒中心，为加州北部三分之二区域的520万户家庭提供天然气与电力供应服务，服务范围涵盖贝克斯菲尔德、圣巴巴拉县北部，几乎延伸至俄勒冈州与内华达州的州界。
斯特赖克是一款八轮装甲战车，衍生自加拿大LAV III步兵战车，而后者源自瑞士莫瓦格食人鱼系列装甲车。该型战车由加拿大通用动力陆地系统公司为美国陆军生产，制造工厂位于安大略省伦敦市。它默认采用8×4四轮驱动，可切换为8×8全轮驱动模式。
PCG vs SYK — 直观对比
营收规模更大
SYK
是对方的1.0倍
$6.9B
营收增速更快
PCG
高出3.6%
11.4%
净利率更高
PCG
高出1.0%
11.8%
两年增速更快
SYK
近两年复合增速
7.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.9B | $7.2B |
| 净利润 | $885.0M | $849.0M |
| 毛利率 | — | 64.5% |
| 营业利润率 | 21.4% | 25.2% |
| 净利率 | 12.9% | 11.8% |
| 营收同比 | 15.0% | 11.4% |
| 净利润同比 | 39.6% | 55.5% |
| 每股收益（稀释后） | $0.39 | $2.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PCGSYK
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.8B | $7.2B | ||
| Q3 25 | $6.3B | $6.1B | ||
| Q2 25 | $5.9B | $6.0B | ||
| Q1 25 | $6.0B | $5.9B | ||
| Q4 24 | $6.6B | $6.4B | ||
| Q3 24 | $5.9B | $5.5B | ||
| Q2 24 | $6.0B | $5.4B |
净利润PCGSYK
| Q1 26 | $885.0M | — | ||
| Q4 25 | $670.0M | $849.0M | ||
| Q3 25 | $850.0M | $859.0M | ||
| Q2 25 | $549.0M | $884.0M | ||
| Q1 25 | $634.0M | $654.0M | ||
| Q4 24 | $674.0M | $546.0M | ||
| Q3 24 | $579.0M | $834.0M | ||
| Q2 24 | $524.0M | $825.0M |
毛利率PCGSYK
| Q1 26 | — | — | ||
| Q4 25 | — | 64.5% | ||
| Q3 25 | — | 63.6% | ||
| Q2 25 | — | 63.8% | ||
| Q1 25 | — | 63.8% | ||
| Q4 24 | — | 64.9% | ||
| Q3 24 | — | 64.0% | ||
| Q2 24 | — | 63.0% |
营业利润率PCGSYK
| Q1 26 | 21.4% | — | ||
| Q4 25 | 18.0% | 25.2% | ||
| Q3 25 | 19.3% | 18.7% | ||
| Q2 25 | 18.6% | 18.5% | ||
| Q1 25 | 20.4% | 14.3% | ||
| Q4 24 | 15.4% | 9.0% | ||
| Q3 24 | 17.3% | 19.7% | ||
| Q2 24 | 18.9% | 19.4% |
净利率PCGSYK
| Q1 26 | 12.9% | — | ||
| Q4 25 | 9.8% | 11.8% | ||
| Q3 25 | 13.6% | 14.2% | ||
| Q2 25 | 9.3% | 14.7% | ||
| Q1 25 | 10.6% | 11.1% | ||
| Q4 24 | 10.2% | 8.5% | ||
| Q3 24 | 9.7% | 15.2% | ||
| Q2 24 | 8.8% | 15.2% |
每股收益（稀释后）PCGSYK
| Q1 26 | $0.39 | — | ||
| Q4 25 | $0.29 | $2.20 | ||
| Q3 25 | $0.37 | $2.22 | ||
| Q2 25 | $0.24 | $2.29 | ||
| Q1 25 | $0.28 | $1.69 | ||
| Q4 24 | $0.30 | $1.41 | ||
| Q3 24 | $0.27 | $2.16 | ||
| Q2 24 | $0.24 | $2.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $4.0B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $22.4B |
| 总资产 | — | $47.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PCGSYK
| Q1 26 | — | — | ||
| Q4 25 | $713.0M | $4.0B | ||
| Q3 25 | $404.0M | $3.3B | ||
| Q2 25 | $494.0M | $2.4B | ||
| Q1 25 | $2.0B | $2.3B | ||
| Q4 24 | $940.0M | $3.7B | ||
| Q3 24 | $895.0M | $3.9B | ||
| Q2 24 | $1.3B | $1.9B |
总债务PCGSYK
| Q1 26 | — | — | ||
| Q4 25 | $57.4B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $53.6B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益PCGSYK
| Q1 26 | — | — | ||
| Q4 25 | $32.5B | $22.4B | ||
| Q3 25 | $32.0B | $21.8B | ||
| Q2 25 | $31.2B | $21.2B | ||
| Q1 25 | $30.7B | $20.9B | ||
| Q4 24 | $30.1B | $20.6B | ||
| Q3 24 | $26.8B | $20.1B | ||
| Q2 24 | $26.3B | $19.8B |
总资产PCGSYK
| Q1 26 | — | — | ||
| Q4 25 | $141.6B | $47.8B | ||
| Q3 25 | $138.2B | $47.1B | ||
| Q2 25 | $136.4B | $46.3B | ||
| Q1 25 | $135.4B | $46.0B | ||
| Q4 24 | $133.7B | $43.0B | ||
| Q3 24 | $132.3B | $43.8B | ||
| Q2 24 | $130.8B | $39.1B |
负债/权益比PCGSYK
| Q1 26 | — | — | ||
| Q4 25 | 1.76× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $2.1B |
| 自由现金流经营现金流 - 资本支出 | — | $1.9B |
| 自由现金流率自由现金流/营收 | — | 26.1% |
| 资本支出强度资本支出/营收 | — | 3.7% |
| 现金转化率经营现金流/净利润 | — | 2.52× |
| 过去12个月自由现金流最近4个季度 | — | $4.3B |
8季度趋势，按日历期对齐
经营现金流PCGSYK
| Q1 26 | — | — | ||
| Q4 25 | $2.0B | $2.1B | ||
| Q3 25 | $2.9B | $1.5B | ||
| Q2 25 | $1.1B | $1.1B | ||
| Q1 25 | $2.8B | $250.0M | ||
| Q4 24 | $1.9B | $1.9B | ||
| Q3 24 | $3.1B | $1.5B | ||
| Q2 24 | $711.0M | $633.0M |
自由现金流PCGSYK
| Q1 26 | — | — | ||
| Q4 25 | $-1.2B | $1.9B | ||
| Q3 25 | $-80.0M | $1.4B | ||
| Q2 25 | $-2.0B | $928.0M | ||
| Q1 25 | $213.0M | $127.0M | ||
| Q4 24 | $-896.0M | $1.7B | ||
| Q3 24 | $526.0M | $1.3B | ||
| Q2 24 | $-1.6B | $481.0M |
自由现金流率PCGSYK
| Q1 26 | — | — | ||
| Q4 25 | -17.6% | 26.1% | ||
| Q3 25 | -1.3% | 22.3% | ||
| Q2 25 | -34.0% | 15.4% | ||
| Q1 25 | 3.6% | 2.2% | ||
| Q4 24 | -13.5% | 25.9% | ||
| Q3 24 | 8.9% | 23.7% | ||
| Q2 24 | -26.5% | 8.9% |
资本支出强度PCGSYK
| Q1 26 | — | — | ||
| Q4 25 | 46.4% | 3.7% | ||
| Q3 25 | 46.9% | 3.1% | ||
| Q2 25 | 52.0% | 3.0% | ||
| Q1 25 | 44.0% | 2.1% | ||
| Q4 24 | 42.6% | 4.1% | ||
| Q3 24 | 43.8% | 3.1% | ||
| Q2 24 | 38.4% | 2.8% |
现金转化率PCGSYK
| Q1 26 | — | — | ||
| Q4 25 | 2.93× | 2.52× | ||
| Q3 25 | 3.35× | 1.79× | ||
| Q2 25 | 1.93× | 1.26× | ||
| Q1 25 | 4.49× | 0.38× | ||
| Q4 24 | 2.87× | 3.54× | ||
| Q3 24 | 5.41× | 1.77× | ||
| Q2 24 | 1.36× | 0.77× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PCG
| Electric | $5.0B | 72% |
| Other | $1.9B | 28% |
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |
